A61K 9/146
With organic macromolecular compounds
Official title: {with organic macromolecular compounds}
A61K9/146 (With organic macromolecular compounds) appears on 1,715 US grants and 3,192 published applications in this corpus.
Search patents in A61K- Granted patents
- 1,715
- Published applications
- 3,192
- Assignees
- 1,358
- Inventors
- 6,012
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 5 | 0 |
| 1977 | 3 | 0 |
| 1978 | 3 | 0 |
| 1979 | 1 | 0 |
| 1980 | 1 | 0 |
| 1981 | 1 | 0 |
| 1982 | 6 | 0 |
| 1983 | 4 | 0 |
| 1984 | 2 | 0 |
| 1985 | 4 | 0 |
| 1986 | 4 | 0 |
| 1987 | 12 | 0 |
| 1988 | 8 | 0 |
| 1989 | 11 | 0 |
| 1990 | 8 | 0 |
| 1991 | 7 | 0 |
| 1992 | 10 | 0 |
| 1993 | 16 | 0 |
| 1994 | 14 | 0 |
| 1995 | 12 | 0 |
| 1996 | 21 | 0 |
| 1997 | 13 | 0 |
| 1998 | 21 | 0 |
| 1999 | 27 | 0 |
| 2000 | 18 | 0 |
| 2001 | 35 | 15 |
| 2002 | 29 | 37 |
| 2003 | 25 | 90 |
| 2004 | 19 | 85 |
| 2005 | 22 | 87 |
| 2006 | 23 | 92 |
| 2007 | 19 | 82 |
| 2008 | 9 | 109 |
| 2009 | 10 | 88 |
| 2010 | 30 | 80 |
| 2011 | 26 | 93 |
| 2012 | 53 | 131 |
| 2013 | 72 | 144 |
| 2014 | 71 | 164 |
| 2015 | 87 | 149 |
| 2016 | 93 | 174 |
| 2017 | 92 | 170 |
| 2018 | 77 | 162 |
| 2019 | 102 | 165 |
| 2020 | 95 | 160 |
| 2021 | 82 | 174 |
| 2022 | 100 | 170 |
| 2023 | 81 | 172 |
| 2024 | 84 | 176 |
| 2025 | 96 | 136 |
| 2026 | 51 | 87 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Nanostructure or microstructure and method for producing same6 Oct 2026US 12,751,923 B2The University of Tokyo
- Implants for release of lipophilic or amphiphilic pharmaceutical substances29 Sep 2026US 12,746,275 B2ReacX Pharmaceuticals, Inc.
- Product8 Sep 2026US 12,728,123 B2Sesh Products Inc.
- Araliadiol dextrin cyclodextrin powdery preparations and method of manufacturing same1 Sep 2026US 12,721,813 B2Ichimaru Pharcos Co., Ltd.
- Method and composition for an improved bioavailability delivery system1 Sep 2026US 12,721,814 B2Americana Pharma LLC
- Compositions and methods for delivery of immune cells to treat un-resectable or non-resected tumor cells and tumor relapse8 Oct 2026US 2026/0308532 A1Fred Hutchinson Cancer Center
- Amorphous cabozantinib particles and uses thereof1 Oct 2026US 2026/0294889 A1Flex Pharma, LLC
- Compositions, devices, and methods for intranasal delivery of dry powder epinephrine1 Oct 2026US 2026/0295182 A1Belhaven BioPharma Inc.
- Glycopyrrolate salts24 Sep 2026US 2026/0284007 A1Journey Medical Corporation
- Compositions, devices, and methods for intranasal delivery of dry powder epinephrine24 Sep 2026US 2026/0284335 A1Belhaven BioPharma Inc.
Most cited
By later US patents
- Surface modified drug nanoparticles993US 5,145,684 ASterling Drug Inc. · 1992
- Surface modified anticancer nanoparticles469US 5,399,363 AEastman Kodak Company · 1995
- Process for preparing therapeutic compositions containing nanoparticles359US 5,510,118 ANanoSystems L.L.C. · 1996
- Polymeric drug formulations332US 5,877,224 ARutgers, The State University of New Jersey · 1999
- Method of manufacturing solid dispersion302US 5,456,923 ANippon Shinyaku Co., Ltd. · 1995